Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of China Sky One Medical, Inc. (“China Sky” or the “Company”) (NasdaqGS: CSKI), concerning whether the company and certain of its officers and directors have violated federal securities laws.
On February 15, 2012, after shares of China Sky plummeted 28%, the Nasdaq Stock Market announced that trading for the Company was halted. China Sky announced that it’s Chairman, President, and Chief Executive Office, Mr. Yanqing Liu, is being treated for a life-threatening illness. In addition, 26 middle-management level employees have resigned, of which 9 were in the accounting department, 2 were in the internal control department, 2 were in the information technology department, 11 were in the sales department, and 2 were in the production center. Although the Company is seeking to recruit personnel, it may not be able to hire qualified personnel in a timely manner, or at all.
Mr. Liu's health concerns and the loss of such management employees are likely to materially adversely affect many aspects of the Company's business, including its ability to maintain customer relationships, meet production schedules, as well as maintain its internal controls.
If you are aware of any facts relating to this investigation, or purchased shares of China Sky, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email
. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.